Jpmorgan Chase & CO Bioventus Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Bioventus Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 283,143 shares of BVS stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

283,143

Previous 299,130 5.34%

Holding current value

$1.83 Million

Previous $3.14 Million 17.52%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$8.76 - $11.05 $140,046 - $176,656	-15,987 Reduced 5.34%	283,143 $2.59 Million
Q4 2024 Feb 12, 2025	BUY	$10.5 - $13.71 $476,595 - $622,296	45,390 Added 17.89%	299,130 $3.14 Million
Q3 2024 Dec 26, 2024	BUY	$5.73 - $11.95 $1.01 Million - $2.11 Million	176,442 Added 228.26%	253,740 $3.03 Million
Q3 2024 Nov 08, 2024	BUY	$5.73 - $11.95 $1.01 Million - $2.11 Million	176,442 Added 228.26%	253,740 $3.03 Million
Q2 2024 Dec 26, 2024	SELL	$3.96 - $6.93 $698,710 - $1.22 Million	-176,442 Reduced 69.54%	77,298 $444,000
Q2 2024 Aug 12, 2024	SELL	$3.96 - $6.93 $115,663 - $202,411	-29,208 Reduced 27.42%	77,298 $444,000
Q1 2024 Dec 26, 2024	SELL	$4.33 - $5.75 $637,523 - $846,595	-147,234 Reduced 58.03%	106,506 $553,000
Q1 2024 May 10, 2024	BUY	$4.33 - $5.75 $215,188 - $285,757	49,697 Added 87.48%	106,506 $553,000
Q4 2023 Dec 26, 2024	SELL	$2.89 - $5.34 $569,130 - $1.05 Million	-196,931 Reduced 77.61%	56,809 $299,000
Q4 2023 Feb 12, 2024	BUY	$2.89 - $5.34 $163,383 - $301,891	56,534 Added 20557.82%	56,809 $299,000
Q3 2023 Nov 14, 2023	SELL	$2.8 - $4.94 $4,211 - $7,429	-1,504 Reduced 84.54%	275 $0
Q2 2023 Aug 11, 2023	SELL	$0.93 - $3.64 $97,165 - $380,303	-104,479 Reduced 98.33%	1,779 $5,000
Q1 2023 May 18, 2023	BUY	$1.07 - $2.95 $26,190 - $72,207	24,477 Added 29.93%	106,258 $113,000
Q1 2023 May 11, 2023	SELL	$1.07 - $2.95 $278,113 - $766,761	-259,919 Reduced 76.07%	81,781 $87,000
Q4 2022 Feb 13, 2023	SELL	$1.81 - $8.14 $19,417 - $87,325	-10,728 Reduced 3.04%	341,700 $892,000
Q3 2022 Nov 14, 2022	SELL	$6.54 - $9.08 $61,181 - $84,943	-9,355 Reduced 2.59%	352,428 $2.47 Million
Q2 2022 Aug 11, 2022	SELL	$6.82 - $13.82 $5,810 - $11,774	-852 Reduced 0.23%	361,783 $2.47 Million
Q1 2022 May 11, 2022	SELL	$11.65 - $15.28 $471,335 - $618,198	-40,458 Reduced 10.04%	362,635 $5.11 Million
Q4 2021 Feb 10, 2022	BUY	$12.37 - $16.77 $440,582 - $597,297	35,617 Added 9.69%	403,093 $5.84 Million
Q3 2021 Nov 12, 2021	BUY	$13.7 - $17.25 $5.03 Million - $6.34 Million	367,476 New	367,476 $5.2 Million

Others Institutions Holding BVS

# of Institutions

154

Shares Held

47.9M

Call Options Held

77.9K

Put Options Held

39.3K

View Full List

About Bioventus Inc.

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $398M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

More about BVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Bioventus Inc. Transaction History